Skip to main content
Figure 7 | Molecular Medicine

Figure 7

From: Surface Expression of Bcl-2 in Chronic Lymphocytic Leukemia and Other B-Cell Leukemias and Lymphomas Without a Breakpoint t(14;18)

Figure 7

smBcl-2 expression in other leukemias. (A–C) smBcl-2 expression in acute lymphocytic leukemia (ALL). Three ALL samples were stained for CD19 (column 1), CD10 (characteristic of ALL; column 2), PE mouse anti-human Bcl-2 (column 3), and FITC mouse anti-human Bcl-2 (column 4). (D–F) smBcl-2 expression in non-CLL lymphoproliferative disorders. ALL (D), HCL (E), and MM (F) samples were FACS sorted for expression of CD19 or a more specific characteristic marker (see Materials and Methods), and then analyzed for smBcl-2 expression and apoptosis by PI. Numbers represent the percentages of smBcl-2+ cells.

Back to article page